Action against misleading ads On 10 March, 2026, the DCGI issued a comprehensive advisory to all drug manufacturers ordering them to stop misleading advertisements and any promotion that could encourage people to use GLP-1 drugs without prescription
There are oral medications, such as a newly FDA-approved Wegovy pill, which my insurance doesnt cover, either
Insurance and Prior Authorization Even if you meet FDA criteria, insurance often adds hoops: Documented lifestyle intervention often 3-6 months of supervised diet, exercise, and behavior change before authorization Step therapy requiring failure of older agents like phentermine or orlistat BMI documentation requiring recent clinical measurement, not self-report Specific comorbidity documentation lab values, imaging, or specialist notes Renewal criteria demonstrating sustained weight loss (often 5% at 6-12 months) for continued coverage Many plans explicitly exclude "drugs used for weight loss" regardless of FDA labeling
Reported mild side effects include nausea, dizziness, and irritation at the injection site, and the compound is generally well tolerated with minimal side effects in research settings
Shakhbazova A, Wu H, Chambers CJ, Sivamani RK